Daewoong Co., Ltd

Insider Reports History

Location
Seongnam Si, Gyeonggi Do, Korea, Republic of
Signature
Daewoong Co., Ltd., By: /s/ Kyu Sung Lim, Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daewoong Co., Ltd:

Company Role Class Num Shares Value Price $ Report Date Ownership
AEON Biopharma, Inc. 10%+ Owner Common Stock, $0.0001 par value per share 11,951,714 $13,152,861 $1.10 21 Jan 2026 Indirect Beneficial Ownership in the 11,951,714 owned by Daewoong Pharmaceutical Co., Ltd
AEON Biopharma, Inc. 10%+ Owner Common Stock, $0.0001 par value per share 58,023 $63,854 $1.10 21 Jan 2026 Direct

Insider Reports Filed by Daewoong Co., Ltd

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AEON AEON Biopharma, Inc. 21 Jan 2026 0 $0 3 10%+ Owner 29 Jan 2026, 21:25
AEON AEON Biopharma, Inc. 12 Apr 2024 1 +$10,000,000 4/A 10%+ Owner 16 Apr 2024, 21:09
AEON AEON Biopharma, Inc. 11 Apr 2024 1 +$10,000,000 4 10%+ Owner 12 Apr 2024, 07:00
AEON AEON Biopharma, Inc. 24 Mar 2024 1 +$5,000,000 4 10%+ Owner 26 Mar 2024, 06:39
AEON AEON Biopharma, Inc. 21 Jul 2023 0 $0 3 10%+ Owner 28 Jul 2023, 07:54